373 related articles for article (PubMed ID: 26586124)
1. Targeted Drug Delivery System for Platinum-based Anticancer Drugs.
Gao C; Zhang Y; Chen J; Wang T; Qian Y; Yang B; Dong P; Zhang Y
Mini Rev Med Chem; 2016; 16(11):872-91. PubMed ID: 26586124
[TBL] [Abstract][Full Text] [Related]
2. [Research progress of the drug delivery system of antitumor platinum drugs with macrocyclic compounds].
Gao CZ; Zhang Y; Chen J; Fei F; Wang TS; Yang B; Dong P; Zhang YJ
Yao Xue Xue Bao; 2015 Jun; 50(6):650-7. PubMed ID: 26521433
[TBL] [Abstract][Full Text] [Related]
3. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.
Najjar A; Rajabi N; Karaman R
Curr Pharm Des; 2017; 23(16):2366-2376. PubMed ID: 28155621
[TBL] [Abstract][Full Text] [Related]
4. Fighting the resistance: rejuvenating anticancer platinum-based drugs.
O'Hare A
Nanomedicine (Lond); 2012 Jul; 7(7):947-8. PubMed ID: 23019670
[TBL] [Abstract][Full Text] [Related]
5. Inorganic Nano-Targeted Drugs Delivery System and Its Application of Platinum-Based Anticancer Drugs.
Chen J; Gao C; Zhang Y; Wang T; Qian Y; Yang B; Dong P; Zhang Y
J Nanosci Nanotechnol; 2017 Jan; 17(1):1-17. PubMed ID: 29616785
[TBL] [Abstract][Full Text] [Related]
6. Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes.
Zhong Y; Jia C; Zhang X; Liao X; Yang B; Cong Y; Pu S; Gao C
Eur J Med Chem; 2020 May; 194():112229. PubMed ID: 32222677
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of platinum-based anticancer complexes.
Butler JS; Sadler PJ
Curr Opin Chem Biol; 2013 Apr; 17(2):175-88. PubMed ID: 23395452
[TBL] [Abstract][Full Text] [Related]
8. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
[TBL] [Abstract][Full Text] [Related]
9. The design and characterization of a novel beta-casein nano-vehicle loaded with platinum anticancer drug for drug delivery.
Divsalar A; Razmi M; Saboury AA; Seyedarabi A
Anticancer Agents Med Chem; 2014; 14(6):892-900. PubMed ID: 24521150
[TBL] [Abstract][Full Text] [Related]
10. Nanocarriers for delivery of platinum anticancer drugs.
Oberoi HS; Nukolova NV; Kabanov AV; Bronich TK
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1667-85. PubMed ID: 24113520
[TBL] [Abstract][Full Text] [Related]
11. Polymer nanoparticle delivery of dichloroacetate and DACH-Pt to enhance antitumor efficacy and lower systemic toxicity.
Yang Q; Cai J; Sun S; Kang X; Guo J; Zhu Y; Yan L; Jing X; Wang Z
Biomater Sci; 2016 Apr; 4(4):661-9. PubMed ID: 26810463
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance.
Xie P; Wang Y; Wei D; Zhang L; Zhang B; Xiao H; Song H; Mao X
J Mater Chem B; 2021 Jul; 9(26):5173-5194. PubMed ID: 34116565
[TBL] [Abstract][Full Text] [Related]
13. The Platin-X series: activation, targeting, and delivery.
Basu U; Banik B; Wen R; Pathak RK; Dhar S
Dalton Trans; 2016 Aug; 45(33):12992-3004. PubMed ID: 27493131
[TBL] [Abstract][Full Text] [Related]
14. Polymeric micelles for targeted tumor therapy of platinum anticancer drugs.
Mochida Y; Cabral H; Kataoka K
Expert Opin Drug Deliv; 2017 Dec; 14(12):1423-1438. PubMed ID: 28290714
[TBL] [Abstract][Full Text] [Related]
15. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
[TBL] [Abstract][Full Text] [Related]
16. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.
Johnstone TC; Suntharalingam K; Lippard SJ
Chem Rev; 2016 Mar; 116(5):3436-86. PubMed ID: 26865551
[TBL] [Abstract][Full Text] [Related]
17. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
[TBL] [Abstract][Full Text] [Related]
18. Platinum formulations as anticancer drugs clinical and pre-clinical studies.
P Farrell N
Curr Top Med Chem; 2011; 11(21):2623-31. PubMed ID: 22039867
[TBL] [Abstract][Full Text] [Related]
19. Progress in synthesis and antitumor activities of estradiol-linked platinum complex.
Zhang P; Yang YW; Shen ZR
Mini Rev Med Chem; 2013 Feb; 13(2):265-72. PubMed ID: 23061622
[TBL] [Abstract][Full Text] [Related]
20. Core-cross-linked micelles synthesized by clicking bifunctional Pt(IV) anticancer drugs to isocyanates.
Duong HT; Huynh VT; de Souza P; Stenzel MH
Biomacromolecules; 2010 Sep; 11(9):2290-9. PubMed ID: 20831272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
